Globus Medical (GMED) Tops Q2 EPS by 12c

Globus Medical (NYSE: GMED) reported Q2 EPS of $0.56, $0.12 better than the analyst estimate of $0.44. Revenue for the quarter came in at $251 million versus the consensus estimate of $224.64 million.

GUIDANCE:

Globus Medical sees FY2021 EPS of $1.89-$2.00, versus the consensus of $1.89. Globus Medical sees FY2021 revenue of $925-950 million, versus the consensus of $926 million.

For earnings history and earnings-related data on Globus Medical (GMED) click here.

You May Also Be Interested In

• Delta Air Lines (DAL) Tops Q2 EPS by 3c, Beats on Revenue; Offers Guidance
• Occidental Petroleum releases Q2 2026 earnings considerations
• WD-40 Co. (WDFC) Tops Q3 EPS by 76c; offers guidance